TENAX THERAPEUTICS, INC. Selling, General and Administrative Expense
TENAX THERAPEUTICS, INC. (TENX) reported Selling, General and Administrative Expense of $5.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-31
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $5.93M, a 4.64% increase year-over-year.
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $5.67M.
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2021-12-31 was $2.30M, a 18.22% increase year-over-year.
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for the quarter ending 2021-09-30 was $2.64M, a 125.11% increase year-over-year.
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2021 was $7.58M, a 42.84% increase from fiscal 2020.
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2020 was $5.31M, a 4.39% increase from fiscal 2019.
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2019 was $5.08M, a 10.08% decline from fiscal 2018.
- TENAX THERAPEUTICS, INC. selling, general and administrative expense for fiscal 2018 was $5.65M, a 0.43% decline from fiscal 2017.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 8 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 530 month | Selling, General and Administrative Expense 533 month | Selling, General and Administrative Expense 536 month | Selling, General and Administrative Expense 539 month | Selling, General and Administrative Expense 542 month | Selling, General and Administrative Expense 545 month | Selling, General and Administrative Expense 554 month | Selling, General and Administrative Expense 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.93M 10-Q · filed 2026-07-31 | $10.97M 10-Q · filed 2026-07-31 | ||||||||||||||
| 2025-06-30 | $5.67M 10-Q · filed 2026-07-31 | $11.33M 10-Q · filed 2026-07-31 | ||||||||||||||
| 2021-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $4.94M derived: sum of 2 quarters · filed 2022-03-29 | $6.21M derived: sum of 3 quarters · filed 2022-03-29 | $7.58M 10-K · filed 2022-03-29 | ||||||||||||
| 2021-09-30 | $2.64M 10-Q · filed 2021-11-15 | $3.91M derived: sum of 2 quarters · filed 2021-11-15 | $5.28M 10-Q · filed 2021-11-15 | $4.48M derived: sum of 4 quarters · filed 2022-03-29 | ||||||||||||
| 2021-06-30 | $1.27M 10-Q · filed 2021-08-16 | $2.64M 10-Q · filed 2021-08-16 | $1.84M derived: sum of 3 quarters · filed 2022-03-29 | $3.01M derived: sum of 4 quarters · filed 2022-03-29 | ||||||||||||
| 2021-03-31 | -$1.37M 10-Q · filed 2021-05-17 | $568.86K derived: sum of 2 quarters · filed 2022-03-29 | $1.74M derived: sum of 3 quarters · filed 2022-03-29 | $2.61M derived: sum of 4 quarters · filed 2022-03-29 | ||||||||||||
| 2020-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $3.12M derived: sum of 2 quarters · filed 2022-03-29 | $3.98M derived: sum of 3 quarters · filed 2022-03-29 | $5.31M 10-K · filed 2022-03-29 | ||||||||||||
| 2020-09-30 | $1.17M 10-Q · filed 2021-11-15 | -$1.17M 10-Q · filed 2020-11-16 | $2.04M derived: sum of 2 quarters · filed 2021-11-15 | $3.36M 10-Q · filed 2021-11-15 | -$3.36M 10-Q · filed 2020-11-16 | $9.50M derived: sum of 4 quarters · filed 2021-11-15 | ||||||||||
| 2020-06-30 | $869.21K 10-Q · filed 2021-08-16 | -$869.21K 10-Q · filed 2020-08-14 | $2.19M 10-Q · filed 2021-08-16 | -$2.19M 10-Q · filed 2020-08-14 | $8.32M derived: sum of 3 quarters · filed 2021-08-16 | $6.98M derived: sum of 4 quarters · filed 2021-08-16 | ||||||||||
| 2020-03-31 | -$1.32M 10-Q · filed 2021-05-17 | $7.45M derived: sum of 2 quarters · filed 2021-05-17 | $6.11M derived: sum of 3 quarters · filed 2021-05-17 | $4.94M derived: sum of 4 quarters · filed 2021-05-17 | ||||||||||||
| 2019-12-31 | $8.78M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $7.43M derived: sum of 2 quarters · filed 2021-04-16 | $6.26M derived: sum of 3 quarters · filed 2021-04-16 | $5.08M 10-K/A · filed 2021-04-16 | ||||||||||||
| 2019-09-30 | -$1.34M 10-Q · filed 2020-11-16 | -$2.51M derived: sum of 2 quarters · filed 2020-11-16 | -$3.69M 10-Q · filed 2020-11-16 | $5.89M derived: sum of 4 quarters · filed 2020-11-16 | ||||||||||||
| 2019-06-30 | -$1.17M 10-Q · filed 2020-08-14 | -$2.35M 10-Q · filed 2020-08-14 | $7.24M derived: sum of 3 quarters · filed 2020-08-14 | $6.05M derived: sum of 4 quarters · filed 2020-08-14 | ||||||||||||
| 2019-03-31 | -$1.18M 10-Q · filed 2020-05-15 | $8.41M derived: sum of 2 quarters · filed 2020-05-15 | $7.22M derived: sum of 3 quarters · filed 2020-05-15 | $5.64M derived: sum of 4 quarters · filed 2020-05-15 | ||||||||||||
| 2018-12-31 | $9.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $8.40M derived: sum of 2 quarters · filed 2020-03-30 | $6.82M derived: sum of 3 quarters · filed 2020-03-30 | $5.65M 10-K · filed 2020-03-30 | ||||||||||||
| 2018-09-30 | -$1.19M 10-Q · filed 2019-11-14 | -$2.77M derived: sum of 2 quarters · filed 2019-11-14 | -$3.93M 10-Q · filed 2019-11-14 | $6.04M derived: sum of 4 quarters · filed 2019-11-14 | ||||||||||||
| 2018-06-30 | -$1.58M 10-Q · filed 2019-08-14 | -$2.74M 10-Q · filed 2019-08-14 | $7.23M derived: sum of 3 quarters · filed 2019-08-14 | $6.18M derived: sum of 4 quarters · filed 2019-08-14 | ||||||||||||
| 2018-03-31 | -$1.16M 10-Q · filed 2019-05-15 | $8.81M derived: sum of 2 quarters · filed 2019-05-15 | $7.75M derived: sum of 3 quarters · filed 2019-05-15 | $5.96M derived: sum of 4 quarters · filed 2019-05-15 | ||||||||||||
| 2017-12-31 | $9.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $8.92M derived: sum of 2 quarters · filed 2019-04-01 | $7.13M derived: sum of 3 quarters · filed 2019-04-01 | $5.68M 10-K · filed 2019-04-01 | ||||||||||||
| 2017-09-30 | -$1.06M 10-Q · filed 2018-11-14 | -$2.85M derived: sum of 2 quarters · filed 2018-11-14 | -$4.30M 10-Q · filed 2018-11-14 | $6.22M derived: sum of 4 quarters · filed 2018-11-14 | ||||||||||||
| 2017-06-30 | -$1.79M 10-Q · filed 2018-08-14 | -$3.24M 10-Q · filed 2018-08-14 | $7.27M derived: sum of 3 quarters · filed 2018-08-14 | $6.01M derived: sum of 4 quarters · filed 2018-08-14 | ||||||||||||
| 2017-03-31 | -$1.45M 10-Q · filed 2018-05-15 | $1.45M 10-Q · filed 2017-05-10 | $9.07M derived: sum of 2 quarters · filed 2018-05-15 | $7.80M derived: sum of 3 quarters · filed 2018-05-15 | $6.56M derived: sum of 4 quarters · filed 2018-05-15 | |||||||||||
| 2016-12-31 | $10.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $9.25M derived: sum of 2 quarters · filed 2018-04-02 | $8.01M derived: sum of 3 quarters · filed 2018-04-02 | $6.25M 10-K · filed 2018-04-02 | ||||||||||||
| 2016-09-30 | -$1.27M 10-Q · filed 2017-11-09 | $1.27M 10-Q · filed 2016-11-09 | -$2.51M derived: sum of 2 quarters · filed 2017-11-09 | -$4.27M 10-Q · filed 2017-11-09 | $4.27M 10-Q · filed 2016-11-09 | |||||||||||
| 2016-06-30 | -$1.24M 10-Q · filed 2017-08-09 | $1.24M 10-Q · filed 2016-08-09 | -$3.00M 10-Q · filed 2017-08-09 | $3.00M 10-Q · filed 2016-08-09 | ||||||||||||
| 2016-03-31 | $1.76M 10-Q · filed 2017-05-10 | |||||||||||||||
| 2015-12-31 | $3.94M 10-K · filed 2017-03-16 | |||||||||||||||
| 2015-10-31 | $1.23M 10-Q · filed 2015-12-10 | $2.60M 10-Q · filed 2015-12-10 | ||||||||||||||
| 2015-09-30 | $1.43M 10-Q · filed 2016-11-09 | $4.98M 10-Q · filed 2016-11-09 | ||||||||||||||
| 2015-07-31 | $1.37M 10-Q · filed 2015-09-09 | |||||||||||||||
| 2015-06-30 | $1.93M 10-Q · filed 2016-08-09 | $3.55M 10-Q · filed 2016-08-09 | ||||||||||||||
| 2015-04-30 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $7.17M 10-K · filed 2017-03-16 | ||||||||||||||
| 2015-03-31 | $1.62M 10-Q · filed 2016-05-10 | |||||||||||||||
| 2015-01-31 | $1.91M 10-Q · filed 2015-03-17 | $3.49M derived: sum of 2 quarters · filed 2015-12-10 | $4.94M 10-Q · filed 2015-03-17 | $14.53M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2014-10-31 | $1.59M 10-Q · filed 2015-12-10 | $3.04M 10-Q · filed 2015-12-10 | $12.62M derived: sum of 3 quarters · filed 2017-03-16 | $14.41M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2014-07-31 | $1.45M 10-Q · filed 2015-09-09 | $11.04M derived: sum of 2 quarters · filed 2017-03-16 | $12.82M derived: sum of 3 quarters · filed 2017-03-16 | $14.24M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||
| 2014-04-30 | $9.59M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $11.37M derived: sum of 2 quarters · filed 2017-03-16 | $12.79M derived: sum of 3 quarters · filed 2017-03-16 | $13.77M 10-K · filed 2017-03-16 | ||||||||||||
| 2014-01-31 | $1.78M 10-Q · filed 2015-03-17 | $3.21M derived: sum of 2 quarters · filed 2015-03-17 | $4.19M 10-Q · filed 2015-03-17 | $4.74M derived: sum of 4 quarters · filed 2016-03-14 | $54.77M 10-Q · filed 2014-03-17 | |||||||||||
| 2013-10-31 | $1.42M 10-Q · filed 2014-12-15 | $2.40M 10-Q · filed 2014-12-15 | $2.95M derived: sum of 3 quarters · filed 2016-03-14 | $4.39M derived: sum of 4 quarters · filed 2016-03-14 | $52.99M 10-Q · filed 2013-12-17 | |||||||||||
| 2013-07-31 | $982.52K 10-Q · filed 2014-09-15 | $1.53M derived: sum of 2 quarters · filed 2016-03-14 | $2.97M derived: sum of 3 quarters · filed 2016-03-14 | $3.40M derived: sum of 4 quarters · filed 2016-03-14 | $51.57M 10-Q · filed 2013-09-17 | |||||||||||
| 2013-04-30 | $549.01K derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $1.99M derived: sum of 2 quarters · filed 2016-03-14 | $2.41M derived: sum of 3 quarters · filed 2016-03-14 | $3.68M 10-KT · filed 2016-03-14 | $50.59M 10-K · filed 2013-06-26 | |||||||||||
| 2013-01-31 | $1.44M 10-Q · filed 2014-03-17 | $1.86M derived: sum of 2 quarters · filed 2014-03-17 | $3.13M 10-Q · filed 2014-03-17 | $4.34M derived: sum of 4 quarters · filed 2014-03-17 | $50.04M 10-Q · filed 2013-03-18 | |||||||||||
| 2012-10-31 | $422.84K 10-Q · filed 2013-12-17 | $1.69M 10-Q · filed 2013-12-17 | $2.89M derived: sum of 3 quarters · filed 2013-12-17 | $4.32M derived: sum of 4 quarters · filed 2013-12-17 | $48.59M 10-Q · filed 2012-12-14 | |||||||||||
| 2012-07-31 | $1.26M 10-Q · filed 2013-09-17 | $2.47M derived: sum of 2 quarters · filed 2013-09-17 | $3.89M derived: sum of 3 quarters · filed 2013-09-17 | $5.55M derived: sum of 4 quarters · filed 2013-09-17 | $48.17M 10-Q · filed 2012-09-19 | |||||||||||
| 2012-04-30 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $2.63M derived: sum of 2 quarters · filed 2013-06-26 | $4.29M derived: sum of 3 quarters · filed 2013-06-26 | $6.09M 10-K · filed 2013-06-26 | $46.91M 10-K · filed 2012-07-25 | |||||||||||
| 2012-01-31 | $1.42M 10-Q · filed 2013-03-18 | $3.08M derived: sum of 2 quarters · filed 2013-03-18 | $4.88M 10-Q · filed 2013-03-18 | $6.89M derived: sum of 4 quarters · filed 2013-03-18 | $45.70M 10-Q · filed 2012-03-15 | |||||||||||
| 2011-10-31 | $1.66M 10-Q · filed 2012-12-14 | $3.46M 10-Q · filed 2012-12-14 | $5.47M derived: sum of 3 quarters · filed 2012-12-14 | $7.75M derived: sum of 4 quarters · filed 2012-12-14 | $44.28M 10-Q · filed 2011-12-15 | |||||||||||
| 2011-07-31 | $1.80M 10-Q · filed 2012-09-19 | $3.81M derived: sum of 2 quarters · filed 2012-09-19 | $6.09M derived: sum of 3 quarters · filed 2012-09-19 | $7.60M derived: sum of 4 quarters · filed 2012-09-19 | $42.62M 10-Q · filed 2011-09-19 | |||||||||||
| 2011-04-30 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $4.29M derived: sum of 2 quarters · filed 2012-07-25 | $5.80M derived: sum of 3 quarters · filed 2012-07-25 | $7.68M 10-K · filed 2012-07-25 | ||||||||||||
| 2011-01-31 | $2.28M 10-Q · filed 2012-03-15 | $3.79M derived: sum of 2 quarters · filed 2012-03-15 | $5.68M 10-Q · filed 2012-03-15 | |||||||||||||
| 2010-10-31 | $1.51M 10-Q · filed 2011-12-15 | $3.39M 10-Q · filed 2011-12-15 | ||||||||||||||
| 2010-07-31 | $1.88M 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |